Pharmacy organizations representing the interests of all pharmacists in the United States have released a joint set of policy recommendations critical to addressing the COVID-19 pandemic. The COVID-19 pandemic continues to put an enormous strain on our nation’s healthcare system, and the supply of qualified healthcare providers is becoming increasingly limited. Pharmacists are currently among those healthcare professionals on the front line, […]
COVID-19: Information from the States
***This page is being continuously updated as we collect more information. Please excuse any formatting challenges for the time being. If you have other info to add, please let us know in the comment box below! The chart below includes NASPA’s compilation of state actions affecting pharmacy. This is a work in progress. The following […]
COVID-19: Hydroxychloroquine, Chloroquine, and Azithromycin
***This page is being continuously updated as we collect more information. Please excuse any formatting challenges for the time being. If you have other info to add, please let us know in the comment box below! The chart below includes NASPA’s compilation of state actions affecting Hydroxychloroquine, Chloroquine, and Azithromycin. This is a work in […]
Pharmacy Organizations Request Flexibility on Hand Sanitizer Compounding
NASPA, along with the Alliance for Pharmacy Compounding, the American Pharmacists Association, and the National Community Pharmacists Association, sent a letter to the FDA this morning requesting clarification and flexibility related to compounding hand sanitizers and anticipating additional health emergency needs. “Our organizations welcome the opportunity to meet with FDA for regular productive and proactive […]
USP Compounding Resources for COVID19
From a USP Healthcare Quality & Safety Team email: “In light of the rapidly evolving COVID-19 pandemic, the demand for garbing and personal protective equipment (PPE) and alcohol-based hand sanitizer is expected to outpace available supply. During this pandemic, USP supports State Boards and other regulators using risk-based enforcement discretion related to the implementation of […]
COVID-19 Emergency Declaration
Several days ago, the Trump Administration announced aggressive actions and regulatory flexibilities to help healthcare providers and states respond to and contain the spread of 2019 Novel Coronavirus Disease (COVID-19). The Centers for Medicare & Medicaid Services (CMS) is taking several actions following President Trump’s declaration of a national emergency due to COVID-19 earlier today. […]